nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy
|
Tan, Qiaoyun |
|
|
71 |
7 |
p. 1681-1691 |
artikel |
2 |
Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumab
|
Bureau, Mathilde |
|
|
71 |
7 |
p. 1747-1756 |
artikel |
3 |
Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigens
|
Hänel, Gerulf |
|
|
71 |
7 |
p. 1705-1718 |
artikel |
4 |
Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy
|
Bellone, Matteo |
|
|
71 |
7 |
p. 1777-1786 |
artikel |
5 |
Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15–16, 2020
|
Bellone, Matteo |
|
|
71 |
7 |
p. 1787-1794 |
artikel |
6 |
Chemical screening identifies novel small molecule activators of natural killer cell cytotoxicity against cancer cells
|
Lee, Grace |
|
|
71 |
7 |
p. 1671-1680 |
artikel |
7 |
Discontinuation of immune checkpoint inhibitor (ICI) above 18 months of treatment in real-life patients with advanced non-small cell lung cancer (NSCLC): INTEPI, a multicentric retrospective study
|
Bilger, Geoffroy |
|
|
71 |
7 |
p. 1719-1731 |
artikel |
8 |
Distribution, phenotype, functional and clinical relevance of CD8+CD103+ tissue-resident memory T cells in human gastric cancer
|
Shen, Yang |
|
|
71 |
7 |
p. 1645-1654 |
artikel |
9 |
Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies
|
Page, Audrey |
|
|
71 |
7 |
p. 1771-1775 |
artikel |
10 |
Endoplasmic reticulum stress-induced release and binding of calreticulin from human ovarian cancer cells
|
Abdullah, Trefa M. |
|
|
71 |
7 |
p. 1655-1669 |
artikel |
11 |
Identification of HLA-A2 restricted epitopes of glypican-3 and induction of CTL responses in HLA-A2 transgenic mice
|
Jin, Xiaoxiao |
|
|
71 |
7 |
p. 1569-1582 |
artikel |
12 |
Identification of prognostic genes in the pancreatic adenocarcinoma immune microenvironment by integrated bioinformatics analysis
|
Wang, Haolan |
|
|
71 |
7 |
p. 1757-1769 |
artikel |
13 |
Metformin inhibits human non-small cell lung cancer by regulating AMPK–CEBPB–PDL1 signaling pathway
|
Lu, Tao |
|
|
71 |
7 |
p. 1733-1746 |
artikel |
14 |
Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis
|
Xue, Jun-shuai |
|
|
71 |
7 |
p. 1633-1644 |
artikel |
15 |
Redirecting host preexisting influenza A virus immunity for cancer immunotherapy
|
Chaganty, Bharat K. R. |
|
|
71 |
7 |
p. 1611-1623 |
artikel |
16 |
Robust immune response stimulated by in situ injection of CpG/αOX40/cGAMP in αPD-1-resistant malignancy
|
Cai, Luya |
|
|
71 |
7 |
p. 1597-1609 |
artikel |
17 |
Targeting the immune checkpoint B7-H3 for next-generation cancer immunotherapy
|
Liu, Chuan |
|
|
71 |
7 |
p. 1549-1567 |
artikel |
18 |
TGF-β orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer
|
Gneo, Luciana |
|
|
71 |
7 |
p. 1583-1596 |
artikel |
19 |
The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study
|
Wang, Wenxian |
|
|
71 |
7 |
p. 1693-1703 |
artikel |
20 |
Treatment efficacy of HER2-mutant lung adenocarcinoma by immune checkpoint inhibitors: a multicenter retrospective study
|
Chu, Xiangling |
|
|
71 |
7 |
p. 1625-1631 |
artikel |